MedPath

Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound

Completed
Conditions
Breast Diseases
Registration Number
NCT06069921
Lead Sponsor
Ma Zhe
Brief Summary

This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to diagnose benign and malignant breast lesions with BI-RADS 4 classification.

Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • female patients with US-visible solid breast masses who underwent biopsy and/or surgical resection, and were classified as having BI-RADS 4 lesions in medical US reports.
Exclusion Criteria
  • preoperative endocrine therapy, chemotherapy, or radiotherapy, preoperative invasive breast operation, insufficient image quality, and no pathological results.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
radiomcis prediction model and the model evaluationImmediately evaluated after the radiomcis prediction model was built

three radiomics models were established using the support vector machines algorithm based on features extracted from the intratumoral, peritumoral, and combined regions of the breast lesions.The models were evaluated using various metrics, including AUC, accuracy, sensitivity, specificity, PPV, and NPV

Secondary Outcome Measures
NameTimeMethod
deep learning prediction model and the model evaluationImmediately evaluated after the deep learning prediction model was built

three deep learning models were established using the support vector machines algorithm based on features extracted from the intratumoral, peritumoral, and combined regions of the breast lesions.The models were evaluated using various metrics, including AUC, accuracy, sensitivity, specificity, PPV, and NPV

Trial Locations

Locations (1)

QianfoshanH

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath